Methotrexate and Wegovy drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Methotrexate (methotrexate sodium) and Wegovy (semaglutide). Common drug interactions include irritable bowel syndrome among females and abdominal pain among males.

The phase IV clinical study analyzes what interactions people have when they take Methotrexate and Wegovy. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Methotrexate?

Methotrexate has active ingredients of methotrexate sodium. It is often used in rheumatoid arthritis. eHealthMe is studying from 604,314 Methotrexate users. Check the latest studies of Methotrexate.

What is Wegovy?

Wegovy has active ingredients of semaglutide. It is often used in weight loss. eHealthMe is studying from 4,887 Wegovy users. Check the latest studies of Wegovy.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 03, 2026

15 people who take Methotrexate and Wegovy together, and have interactions are studied.

Methotrexate and Wegovy drug interactions.

What are the common drug interactions of Methotrexate and Wegovy, by gender? *:

female:

  1. Irritable bowel syndrome
  2. Limb injury
  3. Migraine (headache)
  4. Pain in extremity
  5. Peripheral swelling
  6. Stress
  7. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  8. Blood magnesium decreased
  9. Blood potassium decreased
  10. Arthralgia (joint pain)

male:

  1. Abdominal pain
  2. Abdominal pain upper
  3. Diarrhoea
  4. Insomnia (sleeplessness)
  5. Nausea (feeling of having an urge to vomit)
  6. Vomiting

What are the common drug interactions of Methotrexate and Wegovy, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Abdominal pain
  2. Abdominal pain upper
  3. Blood thyroid stimulating hormone increased
  4. Diarrhoea
  5. Ear pain
  6. Injection site pain
  7. Insomnia (sleeplessness)
  8. Nausea (feeling of having an urge to vomit)
  9. Pain
  10. Palpitations (feelings or sensations that your heart is pounding or racing)

50-59:

  1. Cystitis (inflammation of the wall of the bladder)
  2. Drug ineffective
  3. Dyspepsia (indigestion)
  4. Fall
  5. Fungal infection
  6. Injection site erythema (redness at injection site)
  7. Irritable bowel syndrome
  8. Joint injury
  9. Migraine (headache)
  10. Neck injury

60+:

  1. Pain
  2. Headache (pain in head)
  3. Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
  4. Sinusitis (inflammation of sinus)

What are the existing conditions these people have? *

  1. Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 3 people, 20.00%
  2. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 2 people, 13.33%
  3. Joint Pain: 2 people, 13.33%
  4. Weakness: 1 person, 6.67%
  5. Major Depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings): 1 person, 6.67%
  6. Back Disorder: 1 person, 6.67%
  7. Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it): 1 person, 6.67%
  8. Hair Loss: 1 person, 6.67%
  9. High Blood Pressure: 1 person, 6.67%
  10. Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Methotrexate and Wegovy?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Methotrexate and Wegovy:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Methotrexate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Wegovy:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Methotrexate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Wegovy and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on methotrexate sodium and semaglutide (the active ingredients of Methotrexate and Wegovy, respectively), and Methotrexate and Wegovy (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: